FDA Approved: VIGABATRIN — Supplemental Application (Hikma Pharmaceuticals USA Inc)

View source ↗

Summary

The FDA approved a supplemental application for Vigabatrin from Hikma Pharmaceuticals USA Inc., updating the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Infantile Spasms
• Partial Seizures

Drugs mentioned

• Vigabatrin (Vigabatrin)

Snippet

SUPPL AP for VIGABATRIN (VIGABATRIN)